Maxim Group

Shares of Unusual Machines Inc (NYSE:UMAC) skyrocketed more than 375% over the past month on news that Donald Trump Jr is joining its advisory board. The company is entering military drone components, which is expected to generate "material sales" in the fourth quarter, according to Maxim Group....

At the Benzinga Global Small Cap Conference Thursday, Jason McCarthy, senior managing director at Maxim Group, hosted a panel discussion on how biotech companies are getting back to fundamentals following an extremely disruptive period during the COVID-19 pandemic. The panel discussion included...

Biotricity Inc (OTC: BTCY) has a multi-billion dollar target addressable market, which should expand as an ecosystem is created for solutions to chronic conditions, according to Maxim Group. The Biotricity Analyst: Allen Klee initiated coverage of Biotricity with a Buy rating and a price target of...

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Penny Stocks To Buy With Price Targets Up To 168% According To Analysts Maxim Group & H.C. Wainwright. There is blood in the water...

Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) is set to begin a new phase, according to Maxim Group, after undergoing several changes in strategy, management, capital structure and financing through 2020 and into 2021. The Titan Pharmaceuticals Analyst: Jason McCarthy upgraded the...

Maxim Group has turned bearish on Apple Inc. (NASDAQ: AAPL) amid expectations for revenue to fall short of expectations next year. The Analyst Maxim's Nehal Chokshi downgraded Apple's stock from Hold to Sell with a $190 price target. The Thesis The case for turning bearish on Apple's...

It's déjà vu for biotech investors, who witnessed a wild rally in Bio-Path Holdings Inc (NASDAQ: BPTH) this week. Shares of another thinly traded, nano-cap biotech are clocking double-digit gains for the second consecutive session. TrovaGene Inc (NASDAQ: TROV),...

Fast casual chain Chipotle Mexican Grill, Inc. (NYSE: CMG) boasts an "enviable position" compared to its large-cap restaurant peers, according to Maxim Group. The Analyst Analyst Stephen Anderson upgraded Chipotle Mexican Grill from Hold to Buy with a price target lifted from $...

The bullish case for restaurant chain Potbelly Corp (NASDAQ: PBPB) can now be made for five distinct reasons, according to Maxim Group. The Analyst Maxim's Stephen Anderson upgraded Potbelly from Hold to Buy with a price target lifted from $13 to $15. The Thesis Maxim's neutral stance on...

Dunkin Brands Group Inc (NASDAQ: DNKN) is removing the "Donuts" portion of its iconic name in a move that's consistent with the company's focus on beverages, according to Maxim. The Analyst Maxim Group's Stephen Anderson maintains a Buy rating on Dunkin' Brands with a...

Overstock.com Inc (NASDAQ: OSTK) is one of the beneficiaries of the evolution of blockchain technology, making it an attractive equity, according to Maxim Group.  The Analyst Analyst Allen Klee assumed coverage of the shares of Overstock.com with a Buy rating and $75 price target. The...

Shares of Habit Restaurants Inc (NASDAQ: HABT) are up nearly 70 percent over the last three months, putting an end to Maxim Group's bullish stance on the casual fast food stock.  The Analyst Maxim's Stephen Anderson downgraded Habit Restaurants from Buy to Hold with an...

Cracker Barrel Old Country Store, Inc. (NASDAQ: CBRL) could be positioned for earnings growth, according to Maxim Group.  The Analyst  Maxim analyst Stephen Anderson upgraded Cracker Barrel from Hold to Buy and lifted the price target from $170 to $187. The Thesis Cracker Barrel...

Shares of pizza chain Domino's Pizza, Inc. (NYSE: DPZ) are up nearly 50 percent since the start of 2018, which brings an end to Maxim Group's bullish stance on the stock. The Analyst Analyst Stephen Anderson downgraded Domino's Pizza from Buy to Hold with an unchanged $270 price...

Viking Therapeutics Inc (NASDAQ: VKTX) shares more than doubled Thursday after a 145-percent jump in shares of Madrigal Pharmaceuticals Inc (NASDAQ: MDGL), which announced data from a Phase 2 study of its non-alcoholic steatohepatitis pipeline candidate. NASH is a form of non-alcoholic...